Issues related to funding for university research opportunities via FY 2023 and 2024 federal appropriations, FY 2024 defense authorization bill, Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, additive manufacturing; Implementation and funding for CHIPS and Science Act (P.L. 117-80), including issues related to funding for the Regional Technology and Innovation Hub program; Implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); National Science Foundation (NSF) Engine funding.
Higher Education Act Reauthorization; H.R. 5933 - Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; H.R. 6585 - Bipartisan Workforce Pell Act; H.R.6951 - College Cost Reduction Act; the Department of Education's Notice of Proposed Rulemaking; FY 2023 and 2024 appropriations, including Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, toxic exposure in veterans, and additive manufacturing; Implementation and funding for CHIPS and Science Act (P.L. 117-80), including issues related to funding for the Regional Technology and Innovation Hub program; Implementation of the Consolidated Appropriations Act, 2023 (H.R.2617/P.L. 117-328).
FY 2023 and 2024 Appropriations, including Regional Biocontainment Laboratories (RBLs), PAHPA reauthorization, including S.2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R.4420 - Preparedness and Response Reauthorization Act; and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act.
Cybersecurity research funding; implementation of the FY 2023 National Defense Authorization Act (P.L. 117-347); National Defense Authorization Act for Fiscal Year 2024 (H.R.2670/ P.L. 118-31), including Mission Acceleration Center and DCTC program.
Duration: January 1, 2019
to
present
General Issues: Budget/Appropriations , Education , Health Issues , Defense , Agriculture
Spending: about $1,050,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2019: U.S. Senate, House of Representatives, Agriculture - Dept of (USDA), Veterans Affairs - Dept of (VA), Office of Science & Technology Policy (OSTP), White House Office, Office of Personnel Management (OPM), Defense - Dept of (DOD), Health & Human Services - Dept of (HHS)
Affiliated organizations: University of Louisville Research Foundation
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Hunter Bates
CoS, Sen. McConnell, 2000-02; Legal Cnsl, Sen. McConnell, 1999-00; Chief Cnsl, Senate Rules Committee, 1997-99.
Ed Pagano
Advsr, Sen Harkin, 2014; Dep Asst to the President for Leg Affairs and Sen Liaison, Exec Ofc of the President, 2012-14; CoS, Sen Leahy, 2005-11; Sr Cnsl, Sen Judiciary Comm, 1997-04
Lauren O'Brien
Dep. CoS, Rep. Geoff Davis, 2011-12; Leg. Dir., Rep. Geoff Davis, 2008-11; Leg. Asst., Rep. Geoff Davis, 2006-08; Leg. Cor., Rep. Geoff Davis, 2005; Int., Rep. Sensenbrenner, 2005.
Chase Hieneman
Int, Sen. McConnell, May-June 2010.
Kendall Hussey
Sen Health Labor Pension Comm, 05-08
Josh Teitelbaum
Deputy Assistant Secretary of Commerce, 2014-2016; Staff Director, US Senate HELP Subcommittee on Children and Families, 2013-2014; Legislative Assistant, Senator Kay Hagan, 2011-2013; Legislative Counsel, Congressman Steve Israel, 2009-2011
Anna Abram
Dpty Comm, Pol, Leg, Intnl Affrs, FDA, Mar19Jan21; Mar17Mar19; Spcl Asst HHS, Jan21Mar17; Dec09Jan21; Hlth Dirctr, Sen Burr, Sen Hlth, L&P Comm, Apr09Dec09; Stff Mbr, Sen VA Comm, Feb09Apr09; AsstDrctr, WH Jan0709; LA, LC, SA, SenSantorum, May03Dec06
John Gilliland
Intl trade cnsl, S Fin Comm, Feb 03-Jan 05; leg asst to Sen Lincoln, Jun 01-Feb 03
Lauren OBrien
n/a
Mario Ramirez
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on April 19.
Original Filing: 301564739.xml
Lobbying Issues
Issues related to funding for university research opportunities via FY 2023 and 2024 federal appropriations, FY 2024 defense authorization bill, Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, additive manufacturing; Implementation and funding for CHIPS and Science Act (P.L. 117-80), including issues related to funding for the Regional Technology and Innovation Hub program; Implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); National Science Foundation (NSF) Engine funding.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Higher Education Act Reauthorization; H.R. 5933 - Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; H.R. 6585 - Bipartisan Workforce Pell Act; H.R.6951 - College Cost Reduction Act; the Department of Education's Notice of Proposed Rulemaking; FY 2023 and 2024 appropriations, including Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, toxic exposure in veterans, and additive manufacturing; Implementation and funding for CHIPS and Science Act (P.L. 117-80), including issues related to funding for the Regional Technology and Innovation Hub program; Implementation of the Consolidated Appropriations Act, 2023 (H.R.2617/P.L. 117-328).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2023 and 2024 Appropriations, including Regional Biocontainment Laboratories (RBLs), PAHPA reauthorization, including S.2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R.4420 - Preparedness and Response Reauthorization Act; and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Cybersecurity research funding; implementation of the FY 2023 National Defense Authorization Act (P.L. 117-347); National Defense Authorization Act for Fiscal Year 2024 (H.R.2670/ P.L. 118-31), including Mission Acceleration Center and DCTC program.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on Jan. 19.
Original Filing: 301529712.xml
Lobbying Issues
Issues related to funding for university research opportunities via FY 2023 and 2024 federal appropriations, FY 2024 defense authorization bill, Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, additive manufacturing.; Implementation and funding for CHIPS and Science Act (P.L. 117-80) including issues related to funding for the Regional Technology and Innovation Hub program.; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); National Science Foundation (NSF) Engine funding.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Higher Education Act Reauthorization; the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act (H.R. 5933); The Department of Education's Notice of Proposed Rulemaking.; FY 2023 and 2024 appropriations, including Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, toxic exposure in veterans, additive manufacturing; Implementation and funding for CHIPS and Science Act (P.L. 117-80) including issues related to funding for the Regional Technology and Innovation Hub program; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); National Science Foundation (NSF) Engine funding.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2023 and 2024 Appropriations, including Regional Biocontainment Laboratories (RBLs), PAHPA reauthorization, including S. 2333/H.R. 4420 - Pandemic and All-Hazards Preparedness and Response Act; H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Cybersecurity research funding; implementation of the FY 2023 National Defense Authorization Act (P.L. 117-347); FY 2024 National Defense Authorization Act (PL 118-31), including Mission Acceleration Center, DCTC program.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
2023 Farm Bill; federal support for biopharmaceutical research facilities utilizing plant-based inputs and research into use of agricultural waste for conversion to biofuels.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on Oct. 20, 2023.
Original Filing: 301510488.xml
Lobbying Issues
Issues related to funding for university research opportunities via FY 2023 and 2024 federal appropriations, FY 2024 defense authorization bill, Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, additive manufacturing; Implementation and funding for CHIPS and Science Act (P.L. 117-80) including issues related to funding for the Regional Technology and Innovation Hub program; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Higher Education Act Reauthorization; and the Department of Education's Notice of Proposed Rulemaking; FY 2023 and 2024 appropriations, including Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, toxic exposure in veterans, additive manufacturing; Implementation and funding for CHIPS and Science Act (P.L. 117-80) including issues related to funding for the Regional Technology and Innovation Hub program; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2023 and 2024 Appropriations, including Regional Biocontainment Laboratories (RBLs), PAHPA reauthorization, including S. 2333 - Pandemic and All-Hazards Preparedness and Response Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Cybersecurity research funding; implementation of the FY 2023 National Defense Authorization Act (P.L. 117-347); H.R. 2670/S. 2226 - FY 2024 National Defense Authorization Act, including Mission Acceleration Center, DCTC program and Senate amendment 967 re Vieques.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
2023 Farm Bill; federal support for biopharmaceutical research facilities utilizing plant-based inputs and research into use of agricultural waste for conversion to biofuels; federal support for biopharmaceutical research facilities utilizing plant-based inputs and research into use of agricultural waste for conversion to biofuels.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on July 20, 2023.
Original Filing: 301486324.xml
Lobbying Issues
Issues related to funding for university research opportunities via FY 2023 and 2024 federal appropriations, FY 2024 defense authorization bill, Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, additive manufacturing; Implementation and funding for CHIPS and Science Act (P.L. 117-80) including issues related to funding for the Regional Technology and Innovation Hub program; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Higher Education Act Reauthorization; and the Department of Education's Notice of Proposed Rulemaking; FY 2023 and 2024 appropriations, including Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, toxic exposure in veterans, additive manufacturing; Implementation and funding for CHIPS and Science Act (P.L. 117-80) including issues related to funding for the Regional Technology and Innovation Hub program; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2023 and 2024 Appropriations, including Regional Biocontainment Laboratories (RBLs), implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); PAHPA reauthorization.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Cybersecurity research funding; implementation of the FY 2023 National Defense Authorization Act (P.L. 117-347); H.R. 2670/S. 2226 - FY 2024 National Defense Authorization Act, including Mission Acceleration Center and DCTC program.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
2023 Farm Bill; federal support for biopharmaceutical research facilities utilizing plant-based inputs and research into use of agricultural waste for conversion to biofuels; federal support for biopharmaceutical research facilities utilizing plant-based inputs and research into use of agricultural waste for conversion to biofuels.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Agriculture - Dept of (USDA)
1st Quarter, 2023
In Q1, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on April 20, 2023.
Original Filing: 301462800.xml
Lobbying Issues
Issues related to funding for university research opportunities via FY 2023 and 2024 federal appropriations, FY 2024 defense authorization bill, Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, additive manufacturing.; Implementation and funding for CHIPS and Science Act (P.L. 117-80) including issues related to funding for the Regional Technology and Innovation Hub program.; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Higher Education Act Reauthorization; and the Department of Education's Notice of Proposed Rulemaking.; FY 2023 and 2024 appropriations, including Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, toxic exposure in veterans, additive manufacturing.; Implementation and funding for CHIPS and Science Act (P.L. 117-80) including issues related to funding for the Regional Technology and Innovation Hub program.; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2023 and 2024 Appropriations, including Regional Biocontainment Laboratories (RBLs), implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); PAHPA reauthorization.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Cybersecurity research funding; implementation of the FY 2023 National Defense Authorization Act (P.L. 117-347); FY 2024 National Defense Authorization Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on Jan. 20, 2023.
Original Filing: 301438956.xml
Lobbying Issues
Issues related to funding for university research opportunities via FY 2022 and 2023 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities.; Issues related to research funding for the Regional Technology and Innovation Hub program, concrete, cybersecurity, toxic exposure in veterans, additive manufacturing.; The Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Higher Education Act Reauthorization; Department of Education's Notice of Proposed Rulemaking for Certification Procedures; FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs).; Issues related to research funding for the Regional Technology and Innovation Hub program, cybersecurity, concreate, toxic exposure in veterans, additive manufacturing.; The SBIR and STTR Extension Act of 2022 (S. 4900); the Vieques Recovery and Redevelopment Act (S. 405/HR 1317); the Patent Trial and Appeal Board Reform Act of 2022 (S. 4417); the Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260); COMPETES Act (H.R. 4521)/Creating Helpful Incentives to Produce Semiconductors (CHIPS) and Science Act (H.R. 4346); the Honoring our PACT Act of 2022 (H.R. 3967); and the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs), PREVENT Pandemics Act (S.3799); Honoring our PACT Act of 2022 (H.R. 3967); and the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Cybersecurity research; FY 2023 National Defense Authorization Act (NDAA).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2022
In Q3, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on Oct. 20, 2022.
Original Filing: 301416212.xml
Lobbying Issues
Issues related to funding for university research opportunities via FY 2022 and 2023 federal appropriations, infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities.; Issues related to research funding for EPSCoR, cybersecurity, toxic exposure in veterans, additive manufacturing.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Higher Education Act Reauthorization; Department of Education's Notice of Proposed Rulemaking for Certification Procedures; FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs).; Issues related to research funding for EPSCoR, cybersecurity, toxic exposure in veterans, additive manufacturing.; The SBIR and STTR Extension Act of 2022 (S. 4900); Vieques Recovery and Redevelopment Act (S. 405/H.R. 1317); Patent Trial and Appeal Board Reform Act of 2022 (S. 4417); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260); COMPETES Act (H.R. 4521)/Creating Helpful Incentives to Produce Semiconductors (CHIPS) and Science Act (H.R. 4346); and Honoring our PACT Act of 2022 (H.R. 3967).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs), PREVENT Pandemics Act (S.3799); Honoring our PACT Act of 2022 (H.R. 3967).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2023 National Defense Authorization Act (NDAA).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2022
In Q2, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on July 20, 2022.
Original Filing: 301389461.xml
Lobbying Issues
Funding for university research opportunities via FY 2022 and 2023 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities. Funding support for the University's efforts to address toxic exposure in veterans.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 405/HR 1317); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260); COMPETES Act (H.R. 4521), Honoring our PACT Act of 2022 (H.R. 3967) and Build Back Better Act (H.R. 5376) FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs), PREVENT Pandemics Act (S.3799); Honoring our PACT Act of 2022 (H.R. 3967).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Veterans Affairs - Dept of (VA)
Lobbying Issues
FY 2023 National Defense Authorization Act (NDAA).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2022
In Q1, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on April 19, 2022.
Original Filing: 301362776.xml
Lobbying Issues
Funding for university research opportunities via FY 2022 and 2023 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities. Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 405/HR 1317); American Rescue Plan Act (P.L. 117-2); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260); COMPETES Act (H.R. 4521), Build Back Better Act (H.R. 5376); and Infrastructure Investment and Jobs Act (H.R. 3684). FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; American Rescue Plan Act (P.L. 117-2); FY 2022 and 2023 Appropriations, including Regional Biocontainment Laboratories (RBLs), PREVENT Pandemics Act (S.3799).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2023 National Defense Authorization Act (NDAA).
4th Quarter, 2021
In Q4, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on Jan. 20, 2022.
Original Filing: 301333824.xml
Lobbying Issues
Funding for university research opportunities via FY 2021 and 2022 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities. Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP)
Lobbying Issues
Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 405/HR 1317); American Rescue Plan Act (P.L. 117-2); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260); Build Back Better Act (H.R. 5376); and Infrastructure Investment and Jobs Act (H.R. 3684). FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
National Defense Authorization Act (NDAA) 2022.
3rd Quarter, 2021
In Q3, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on Oct. 20, 2021.
Original Filing: 301309054.xml
Lobbying Issues
Funding for university research opportunities via FY 2021 and 2022 federal appropriations, Infrastructure and defense authorization bills, Regional Biocontainment Laboratories (RBLs) and other federal opportunities. Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; The Vieques Recovery and Redevelopment Act (S. 4398) and related provisions in House Build Back Better legislation (H.R. 5376); preserve charitable donations from Individual Retirement Accounts in Build Back Better legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP)
Lobbying Issues
Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 405/HR 1317); American Rescue Plan Act (P.L. 117-2); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260); Build Back Better Act (H.R. 5376); and Infrastructure Investment and Jobs Act (H.R. 3684). FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
National Defense Authorization Act (NDAA) 2022.
2nd Quarter, 2021
In Q2, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on July 20, 2021.
Original Filing: 301286181.xml
Lobbying Issues
Funding for university research opportunities via FY 2021 and 2022 federal appropriations, Infrastructure and defense authorization bills, and other federal opportunities. Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; The Vieques Recovery and Redevelopment Act (S. 4398); American Rescue Plan Act (P.L. 117-2).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 4398/H.R. 4605); American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs); Endless Frontier Act/U.S. Innovation And Competition Act Of 2021 (S. 1260), and infrastructure proposals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives White House Office
Lobbying Issues
Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations, including Regional Biocontainment Laboratories (RBLs).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
In Q1, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on April 20, 2021.
Original Filing: 301267167.xml
Lobbying Issues
Funding for university research opportunities via FY 2021 and 2022 federal appropriations, defense authorization bills, and other federal opportunities. Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; The Vieques Recovery and Redevelopment Act (S. 4398); American Rescue Plan Act (P.L. 117-2).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Higher Education Act Reauthorization; Issues related to the Higher Education Emergency Relief Fund (HEERF); The Vieques Recovery and Redevelopment Act (S. 4398); American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations; Endless Frontier Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Funding support for the University's efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2020
In Q4, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on Jan. 20, 2021.
Original Filing: 301241172.xml
Lobbying Issues
Funding for university research opportunities via Fiscal Year 2020 and Fiscal Year 2021 federal appropriations, defense authorization bills, and other federal opportunities; The Vieques Recovery and Redevelopment Act (S. 4398); Funding support for university efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Higher Education Act Reauthorization; College Transparency Act (S. 800); OPM Federal Academic Alliance, Education issues related to The Families First Coronavirus Response Act (H.R. 6201); The CARES Act (H.R. 748), the Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074), the HEROES Act (H.R. 6800), Health, Economic Assistance, Liability Protection and Schools (HEALS) Act (S. 1624); Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act (S. 4775); and the Consolidated Appropriations Act, 2021 (H.R. 133); Issues related to the Higher Education Emergency Relief (HEER) Fund.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Personnel Management (OPM)
Lobbying Issues
Funding support for the University's efforts to address coronavirus in the metro area; support for funding for health providers related to The Families First Coronavirus Response Act (H.R. 6201); The CARES Act (H.R. 748), the Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074), the HEROES Act (H.R. 6800), Health, Economic Assistance, Liability Protection and Schools (HEALS) Act (S. 1624) and Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act (S. 4775); Consolidated Appropriations Act, 2021 (H.R. 133); the Vieques Recovery and Redevelopment Act (S. 4398); and funding support for university efforts to address coronavirus in the metro area, including funding for wastewater testing and COVID-19 therapeutics.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Defense Civilian Training Corps.; National Defense Authorization Act (NDAA) 2021 (H.R. 6395, S. 4049).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2020
In Q3, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on Oct. 20, 2020.
Original Filing: 301223374.xml
Lobbying Issues
Funding for university research opportunities via Fiscal Year 2020 and Fiscal Year 2021 federal appropriations, defense authorization bills, and other federal opportunities; The Vieques Recovery and Redevelopment Act (S. 4398).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Higher Education Act Reauthorization; Education issues related to The Families First Coronavirus Response Act (H.R. 6201); The CARES Act (H.R. 748), the Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074), the HEROES Act (H.R. 6800), Health, Economic Assistance, Liability Protection and Schools (HEALS) Act (S. 1624) and Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act (S. 4775).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Funding support for the University's efforts to address coronavirus in the metro area; support for funding for health providers related to The Families First Coronavirus Response Act (H.R. 6201); The CARES Act (H.R. 748), the Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074), the HEROES Act (H.R. 6800), Health, Economic Assistance, Liability Protection and Schools (HEALS) Act (S. 1624) and Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act (S. 4775); S. 4398, Vieques Recovery and Redevelopment Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Defense Civilian Training Corps.; National Defense Authorization Act (NDAA) 2021 (H.R. 6395, S. 4049).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2020
In Q2, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on July 19, 2020.
Original Filing: 301193758.xml
Lobbying Issues
Funding for university research opportunities via Fiscal Year 2020 and Fiscal Year 2021 federal appropriations, defense authorization bills, and other federal opportunities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Education issues related to the CARES Act (H.R. 748), the Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074),and the HEROES Act (H.R. 6800).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Funding support for the University's efforts to address coronavirus in the metro area; support for funding for health providers related to the CARES Act (H.R. 748), the Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074, and the HEROES Act (HR 6800).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Defense Civilian Training Corps.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2020
In Q1, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on April 20, 2020.
Original Filing: 301173549.xml
Lobbying Issues
Funding for university research opportunities via Fiscal Year 2020 and Fiscal Year 2021 federal appropriations, defense authorization bills, and other federal opportunities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Education issues related to the CARES Act (H.R. 748).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Education regarding and funding support for the University's efforts to address coronavirus in the metro area; support for funding for health providers related to the CARES Act (H.R. 748) and the Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Defense Civilian Training Corps.
Agencies Lobbied
U.S. Senate Defense - Dept of (DOD)
4th Quarter, 2019
In Q4, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on Jan. 20, 2020.
Original Filing: 301123730.xml
Lobbying Issues
Funding for university research opportunities via Fiscal Year 2020 federal appropriations, defense authorization bills, and other federal opportunities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD)
Lobbying Issues
Reauthorization of the Higher Education Act; preserve TRIO program; support grant and loan opportunities for undergraduate and graduate students.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to the University of Louisville's acquisition of the KentuckyOne Health.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2019
In Q3, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on Oct. 20, 2019.
Original Filing: 301073086.xml
Lobbying Issues
Funding for university research opportunities via Fiscal Year 2020 federal appropriations, defense authorization bills, and other federal opportunities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Reauthorization of the Higher Education Act; preserve TRIO program; support grant and loan opportunities for undergraduate and graduate students.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2019
In Q2, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on July 22, 2019.
Original Filing: 301059101.xml
Lobbying Issues
Funding for university research opportunities via Fiscal Year 2020 federal appropriations and defense authorization bills; support for continued funding for the Institutional Development Award (IDeA) program and pediatric clinical trials.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reauthorization of the Higher Education Act; preserve TRIO program; support grant and loan opportunities for undergraduate and graduate students.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
In Q1, AKIN GUMP STRAUSS HAUER & FELD lobbied for University of Louisville , earning $50,000. The report was filed on April 22, 2019.
Original Filing: 301038260.xml
Lobbying Issues
Funding for university research opportunities via federal appropriations bills, including Consolidated Appropriations Act for FY 2019.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Reauthorization of the Higher Education Act; H.R. 1652, Veteran Education Empowerment Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate